Attached files
file | filename |
---|---|
EX-99.1 - WaferGen Bio-systems, Inc. | v207860_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of
report (Date of earliest event reported): January 7, 2011
WaferGen
Bio-systems, Inc.
(Exact
name of registrant as specified in its charter)
Nevada
|
333-136424
|
90-0416683
|
||
(State
or other jurisdiction
|
(Commission
|
(I.R.S.
Employer
|
||
of
incorporation)
|
File
Number)
|
Identification
No.)
|
||
7400
Paseo Padre Parkway
Fremont,
CA
|
94555
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (510) 651-4450
Not
Applicable
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction
A.2. below):
*
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
*
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
*
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
*
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01. Regulation FD Disclosure.
On
January 7, 2011, WaferGen Bio-systems, Inc. (the “Company”) issued a press
release announcing that it will present an overview of the Company at the Fourth
Annual OneMedForum Business Development and Investment Conference at the Sir
Francis Drake Hotel in San Francisco on Wednesday, January 12, 2011 at 2:30 p.m.
Pacific Time. This presentation may be accessed by the public via
live webcast at www.wafergen.com. The webcast will be archived until
April 12, 2011. A copy of the press release issued by the Company is
attached hereto as Exhibit 99.1
The
information in this Current Report on Form 8−K, including Exhibit 99.1, shall
not be deemed “filed” for the purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liability of that section,
nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as
amended, except as we may specifically state in any such filing.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit
No.
|
Description
|
|
99.1
|
Press
release issued on January 7, 2011
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
WaferGen
Bio-systems, Inc.
|
||
Date:
January 7, 2011
|
By:
|
/s/
Don Huffman
|
Don
Huffman
|
||
Chief
Financial Officer
|
2